Inhibrx
INBX
$34.30
Share price
0.44%
Change (1 day)
29.68%
Change (1 year)
Categories
Inhibrx (INBX) - P/B ratio
P/B ratio as of May 2024 : 37.4
According to Inhibrx's latest financial reports the company has a price-to-book ratio of 37.4.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Inhibrx - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 41.3 | 123.49% |
| 2022-12-31 | 18.5 | -41.58% |
| 2021-12-31 | 31.6 | 92.07% |
| 2020-12-31 | 16.5 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.82 | -92.46% | 🇺🇸 USA |